TerrAscend Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

TerrAscend wird ein Gewinn- und Umsatzwachstum von 86.5% bzw. 10.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 95.7% pro Jahr wachsen soll.

Wichtige Informationen

86.5%

Wachstumsrate der Gewinne

95.7%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	54.4%
Wachstumsrate der Einnahmen	10.6%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	29 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Is TerrAscend (TSE:TSND) A Risky Investment?

Sep 03

TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt

Apr 25

What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash

Mar 10

TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors

Jul 03

TerrAscend (CSE:TER) Is Making Moderate Use Of Debt

Mar 06

Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?

Dec 21

Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates

Aug 14

Is TerrAscend (CSE:TER) Using Too Much Debt?

Jul 15

Gewinn- und Umsatzwachstumsprognosen

TSX:TSND - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	395	N/A	N/A	N/A	1
12/31/2025	332	-17	13	29	6
12/31/2024	314	-39	33	42	6
6/30/2024	334	-80	34	45	N/A
3/31/2024	329	-87	21	32	N/A
12/31/2023	317	-91	17	27	N/A
9/30/2023	300	-50	3	25	N/A
6/30/2023	277	-342	-6	18	N/A
3/31/2023	269	-311	-35	1	N/A
12/31/2022	248	-304	-69	-26	N/A
9/30/2022	212	-298	-77	-37	N/A
6/30/2022	195	59	-100	-57	N/A
3/31/2022	189	13	-94	-57	N/A
12/31/2021	194	13	-72	-32	N/A
9/30/2021	211	-96	-114	-70	N/A
6/30/2021	200	-165	-102	-53	N/A
3/31/2021	175	-144	-78	-30	N/A
12/31/2020	132	-125	-82	-37	N/A
9/30/2020	118	-159	-47	-1	N/A
6/30/2020	99	-156	-41	-2	N/A
3/31/2020	75	-155	-58	-25	N/A
12/31/2019	64	-161	-74	-40	N/A
9/30/2019	48	-44	-54	-32	N/A
6/30/2019	30	-33	-52	-33	N/A
3/31/2019	16	-23	-43	-26	N/A
12/31/2018	5	-16	-30	-20	N/A
9/30/2018	1	-9	-29	-21	N/A
6/30/2018	0	-8	-23	-17	N/A
3/31/2018	N/A	-7	N/A	-6	N/A
12/31/2017	N/A	-5	N/A	-3	N/A
9/30/2017	N/A	-5	N/A	-3	N/A
6/30/2017	N/A	-4	N/A	0	N/A
3/31/2017	N/A	-1	N/A	-1	N/A
12/31/2016	N/A	-1	N/A	0	N/A
12/31/2015	N/A	-1	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: TSND wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: TSND wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: TSND wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: TSNDDie Einnahmen des Unternehmens (10.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (6.9% pro Jahr).

Hohe Wachstumseinnahmen: TSNDDie Einnahmen des Unternehmens (10.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von TSND in 3 Jahren voraussichtlich hoch sein wird

TerrAscend Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates have been downgraded.

TerrAscend Corp. Raises Earnings Guidance for 2023

Consensus EPS estimates fall by 17%

Consensus EPS estimates fall by 800%

Consensus forecasts updated

Consensus EPS estimates fall by 1,223%

Recent updates

TerrAscend Corp. to Report Q3, 2024 Results on Nov 06, 2024

TerrAscend Corp. announced that it has received $140 million in funding from Wdb Holding Ca, Inc., Wdb Holding PA Inc, FocusGrowth Asset Management, LP, Hempaid, LLC, Moose Curve Holdings, LLC and other investors

New minor risk - Profitability

New minor risk - Share price stability

Is TerrAscend (TSE:TSND) A Risky Investment?

New minor risk - Shareholder dilution

TerrAscend Corp. (TSX:TSND) announces an Equity Buyback for 10,000,000 shares, representing 3.43% for $10 million.

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

TerrAscend Corp. to Report Q2, 2024 Results on Aug 08, 2024

New minor risk - Shareholder dilution

New minor risk - Share price stability

Now 23% overvalued after recent price rise

First quarter 2024 earnings: EPS misses analyst expectations

Terrascend Corp. Launches Legend Mini Pre-Roll Packs in New Jersey

TerrAscend (TSE:TSND) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates have been downgraded.

TerrAscend Corp. to Report Q1, 2024 Results on May 09, 2024

TerrAscend Corp., Annual General Meeting, Jun 17, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings: EPS misses analyst expectations

What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash

TerrAscend Corp. to Report Fiscal Year 2023 Results on Mar 14, 2024

Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%

TerrAscend Corp. Announces the Expansion of its Valhalla Product Offering to Include One of the First 100Mg Edibles in the Keystone State

New minor risk - Shareholder dilution

Is TerrAscend (TSE:TSND) A Risky Investment?

New minor risk - Shareholder dilution

TerrAscend Corp. Raises Earnings Guidance for 2023

TerrAscend Corp. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Shareholder dilution

Consensus EPS estimates fall by 17%

New minor risk - Profitability

TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt

Second quarter 2023 earnings: EPS misses analyst expectations

TerrAscend Corp. Reports Impairment for the Second Quarter Ended June 30, 2023

New minor risk - Profitability

TerrAscend Corp. to Report Q2, 2023 Results on Aug 10, 2023

TerrAscend Corp. (CNSX:TER) acquired Herbiculture Inc. for $8.25 million.

TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors

TerrAscend Corp. (CNSX:TER) completed the acquisition of Derby 1, LLC.

TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Hempaid, LLC for $6.8 million.

TerrAscend Corp. announced that it expects to receive $15 million in funding

TerrAscend Corp. announced that it expects to receive $15 million in funding

TerrAscend Corp. (CNSX:TER) entered into a definitive agreement to acquire Derby 1, LLC for $22.1 million.

An unknown buyer acquired Facility located in Mississauga, Canada from TerrAscend Corp. (CNSX:TER) for CAD19.7 million.

Consensus EPS estimates fall by 800%

First quarter 2023 earnings: EPS misses analyst expectations

Chief Financial Officer recently bought CA$99k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Director recently sold CA$59k worth of stock

TerrAscend (CSE:TER) Is Making Moderate Use Of Debt

Terrascend Appoints Jeroen De Beijer as Chief People and Culture Officer

TerrAscend Corp. (CNSX:TER) completed the acquisition of Allegany Medical Marijuana Dispensary from Moose Curve Holdings, LLC.

Now 25% undervalued after recent price drop

Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?

Now 22% undervalued

TerrAscend Corp. Appoints Ira Duarte to Its Board of Directors

Consensus forecasts updated

Consensus EPS estimates fall by 1,223%

Less than half of directors are independent

TerrAscend Corp. to Report Q3, 2022 Results on Nov 14, 2022

Investor sentiment improved over the past week

Terrascend Corp. Announces Executive Changes

TerrAscend Corp. (CNSX:TER) acquired KISA Enterprises MI, LLC and KISA Holdings, LLC.

Consensus revenue estimates fall by 18%

Investor sentiment deteriorated over the past week

Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind